Rice A M, Wood J A, Milross C G, Collins C J, Case J, Nordon R E, Vowels M R
Children's Cancer Institute Australia for Medical Research, Sydney Children's Hospital, Randwick, NSW, Australia.
J Hematother Stem Cell Res. 2001 Feb;10(1):157-65. doi: 10.1089/152581601750098435.
Cytokine-mediated expansion has been proposed and successfully used to facilitate engraftment post transplantation. This study examined whether cryopreservation following expansion has a detrimental effect on the ability of cells to engraft, using the NOD-SCID mouse model. Cord blood (CB) CD34(+) cells were incubated for 7 days with stem cell factor (SCF), flt-3 ligand (FL), and megakaryocyte growth and development factor (MGDF). Expanded CD34(+) cells were transplanted into NOD-SCID mice either fresh or following cryopreservation and thawing. After thawing, recovery of nucleated cells was 94%, of CD34 cells was 63%, and of day-14 progenitors was 17%. The loss of day-14 progenitor cells among the thawed expanded cells did not influence the kinetics of human engraftment in the mouse. Bone marrow (BM) of mice transplanted with thawed expanded CD34(+) cells (14 +/- 3.9%) showed significantly higher levels of human engraftment than mice transplanted with fresh expanded CD34(+) cells (1.5 +/- 0.5%, p = 0.0064). Thawed expanded CD34(+) cells had significantly higher SCID Engrafting Potential (SEP) than freshly expanded CD34(+) cells (p < 0.001). Results suggest that prior cryopreservation does not prevent expanded cells engrafting in NOD-SCID mice.
细胞因子介导的扩增已被提出并成功用于促进移植后的植入。本研究使用NOD-SCID小鼠模型,检测扩增后的冷冻保存是否会对细胞的植入能力产生不利影响。将脐血(CB)CD34(+)细胞与干细胞因子(SCF)、fms样酪氨酸激酶3配体(FL)和巨核细胞生长发育因子(MGDF)一起孵育7天。扩增后的CD34(+)细胞在新鲜状态下或经过冷冻保存和解冻后移植到NOD-SCID小鼠体内。解冻后,有核细胞的回收率为94%,CD34细胞为63%,第14天祖细胞为17%。解冻后的扩增细胞中第14天祖细胞的损失并不影响小鼠体内人源细胞植入的动力学。移植了解冻后扩增的CD34(+)细胞的小鼠骨髓(BM)中人源细胞植入水平(14±3.9%)显著高于移植新鲜扩增的CD34(+)细胞的小鼠(1.5±0.5%,p = 0.0064)。解冻后扩增的CD34(+)细胞的严重联合免疫缺陷植入潜能(SEP)显著高于新鲜扩增的CD34(+)细胞(p < 0.001)。结果表明,预先冷冻保存并不妨碍扩增后的细胞在NOD-SCID小鼠体内植入。